Stockscreener 앱 받기
1.40
0.00%
0.00
전일 마감가:
$1.40
열려 있는:
$1.42
하루 거래량:
34,943
Relative Volume:
0.05
시가총액:
$8.24M
수익:
$3,000
순이익/손실:
$-8.79M
주가수익비율:
-0.6656
EPS:
-2.1033
순현금흐름:
$-8.46M
1주 성능:
+6.87%
1개월 성능:
+2.94%
6개월 성능:
-47.76%
1년 성능:
-41.42%
1일 변동 폭
$1.35
$1.42
1주일 범위
$1.25
$1.43
52주 변동 폭
$1.00
$3.20
Biocardia Inc Stock (BCDA) Company Profile
명칭
Biocardia Inc
전화
650-226-0123
주소
320 SOQUEL WAY, SUNNYVALE, CA
BCDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.32 | 4.40B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.06 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.3926 | 189.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2523 | 554.19M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.38 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-16 | 다운그레이드 | Dawson James | Buy → Neutral |
Biocardia Inc 주식(BCDA)의 최신 뉴스
Price action breakdown for BioCardia Inc.July 2025 Snapshot & High Accuracy Trade Alerts - newser.com
How to forecast BioCardia Inc. trends using time seriesQuarterly Profit Review & Reliable Price Action Trade Plans - newser.com
Is BioCardia Inc. forming a bottoming baseMarket Performance Recap & Reliable Price Breakout Alerts - newser.com
Why BioCardia Inc. stock could benefit from AI revolution2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - newser.com
Can BioCardia Inc. stock sustain institutional interestJuly 2025 Decliners & Weekly Breakout Watchlists - newser.com
How BioCardia Inc. (6JU0) stock responds to job market shiftsWeekly Stock Recap & High Return Stock Watch Alerts - newser.com
What to expect from BioCardia Inc. in the next 30 daysTrade Performance Summary & Long-Term Capital Growth Strategies - newser.com
BioCardia’s CardiAMP HF II Phase 3 Trial Reaches Milestone With First Patient Enrollment At University Of Wisconsin - Pulse 2.0
Will BioCardia Inc. (6JU0) stock return to pre crash levelsQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Can BioCardia Inc. stock hit record highs againJuly 2025 Gainers & Technical Pattern Based Buy Signals - newser.com
Applying sector rotation models to BioCardia Inc.Quarterly Portfolio Review & Fast Exit and Entry Trade Guides - newser.com
Smart tools for monitoring BioCardia Inc.’s price actionQuarterly Trade Report & Safe Entry Momentum Tips - newser.com
Is BioCardia Inc. stock positioned for digital transformationGap Up & Real-Time Buy Signal Alerts - newser.com
Measuring BioCardia Inc.’s beta against major indicesMarket Activity Recap & Daily Technical Forecast Reports - newser.com
What is the fair value estimate for BioCardia Inc. (6JU0) stock in 2025Day Trade & Real-Time Price Movement Reports - newser.com
What catalysts could drive BioCardia Inc. stock higherAnalyst Downgrade & Safe Entry Zone Identification - newser.com
Published on: 2025-10-31 00:08:58 - newser.com
Why BioCardia Inc. (6JU0) stock appears on watchlistsNew Guidance & Free Real-Time Volume Trigger Notifications - newser.com
Custom watchlist performance reports with BioCardia Inc.Risk Management & Consistent Income Trade Recommendations - newser.com
BioCardia, Inc. (BCDA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
BioCardia enrolls first patient at UW in phase 3 heart failure trial - Investing.com Philippines
BioCardia Advances Phase 3 CardiAMP HF II Trial - TipRanks
BioCardia, Inc. Enrolls First Patient in Phase 3 CardiAMP HF II Trial - TradingView
BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial - The Manila Times
BCDA reports first patient enrollment in Phase 3 CardiAMP HF II - Stock Titan
BioCardia (NASDAQ: BCDA) reports first UW patient enrolled in Phase 3 CardiAMP HF II - Stock Titan
BCDA amends Q2 filing; going concern flagged, $769k ATM raised - Stock Titan
Using flow based indicators on BioCardia Inc.Weekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Biocardia Inc (BCDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Biocardia Inc 주식 (BCDA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Blank Andrew Scott | Director |
Sep 19 '25 |
Buy |
1.25 |
288,000 |
360,000 |
634,023 |
| Altman Peter | President and CEO |
Sep 19 '25 |
Buy |
1.25 |
48,000 |
60,000 |
216,762 |
| Altman Peter | President and CEO |
Aug 22 '25 |
Buy |
1.83 |
700 |
1,281 |
168,762 |
| Altman Peter | President and CEO |
Aug 13 '25 |
Buy |
1.83 |
100 |
183 |
168,062 |
| Altman Peter | President and CEO |
Aug 12 '25 |
Buy |
1.75 |
400 |
700 |
167,962 |
| Altman Peter | President and CEO |
Aug 11 '25 |
Buy |
1.76 |
1,700 |
2,989 |
167,562 |
| McClung David | Chief Financial Officer |
Jun 30 '25 |
Buy |
2.08 |
4,819 |
9,999 |
47,950 |
| Altman Peter | President and CEO |
Jun 30 '25 |
Buy |
2.08 |
24,096 |
49,999 |
165,862 |
| STERTZER SIMON H | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
192,654 |
| Blank Andrew Scott | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
346,023 |
0.03%
0.32%
자본화:
|
볼륨(24시간):